MedTrace Logo

Immediate Post-Operative Anesthesia With Either Lidocaine or Bupivacaine

NCT06293807 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2024-03-08

No results posted yet for this study

Summary

Immediate post-suturing administration of either one of two dental anesthetic solutions or a placebo prior to dismissal.

Conditions

  • Periodontal Diseases

Interventions

DRUG

Xylocaine 2 % with 1:100,000 epinephrine

Local anesthetic used during dental procedures

DRUG

Bupivicaine 0.5% with 1:200,000 epinephrine

Local anesthetic used during dental procedures

OTHER

Placebo

0.9% Normal Saline solution used in place of local anesthetic

Sponsors & Collaborators

  • The University of Texas Health Science Center at San Antonio

    lead OTHER

Principal Investigators

  • David Deas, DDS, MS · The University of Texas Health Science Center at San Antonio

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-06
Primary Completion
2023-04-16
Completion
2023-04-16
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06293807 on ClinicalTrials.gov